Investor Perspectives – How to Solve the Biotech/Life Sciences Problem: Primary Trends and What Makes for a Successful Company

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about primary trends and what makes for a successful company in this segment.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels 1:17
Carter Williams, CEO and Managing Partner, iSelect Fund 5:58
Maximilian Bade, Founding Partner, Nucleus Capital 15:08
Ron Paliwoda, President, Paliwoda Group 17:09
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund 20:09
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures 22:57
Mark Groper, Chief Executive Officer, Orion Biotechnology 30:45

We hope you enjoy the show.
_______________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org     

Check out our other podcasts here: https://investorconnect.org/  
For Investors check out: https://tencapital.group/investor-landing/   
For Startups check out: https://tencapital.group/company-landing/   
For eGuides check out: https://tencapital.group/education/  
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact [e-mail]  

Music courtesy of Bensound.